Merete Nordentoft Selected Research

4,4'-dibenzamido-2,2'-stilbenedisulfonic acid

1/2021

Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merete Nordentoft Research Topics

Disease

54	Schizophrenia (Dementia Praecox) 07/2022 - 01/2002
35	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2002
30	Mental Disorders (Mental Disorder) 10/2022 - 01/2013
10	Infections 01/2022 - 12/2011
8	Bipolar Disorder (Manic Depressive Psychosis) 04/2022 - 04/2014
7	Substance-Related Disorders (Drug Abuse) 05/2022 - 04/2005
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 07/2022 - 01/2015
5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 01/2018
5	Poisoning 01/2020 - 01/2006
4	Mood Disorders (Mood Disorder) 01/2019 - 04/2005
3	Wounds and Injuries (Trauma) 01/2018 - 01/2015
3	Depressive Disorder (Melancholia) 01/2018 - 07/2015
2	Sleep Wake Disorders 12/2022 - 10/2022
2	COVID-19 09/2022 - 05/2022
2	Major Depressive Disorder (Major Depressive Disorders) 07/2022 - 01/2021
2	Neurodevelopmental Disorders 01/2022 - 01/2013
2	Hallucinations (Hallucination) 11/2021 - 12/2020
2	Weight Gain 01/2021 - 01/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2013
2	Neoplasms (Cancer) 01/2021 - 01/2013
2	Dementia (Dementias) 01/2020 - 07/2013
2	Type 2 Diabetes Mellitus (MODY) 10/2019 - 07/2013
2	Alcoholism (Alcohol Abuse) 11/2011 - 04/2006
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2022
1	Narcolepsy 12/2022
1	Postpartum Depression (Post-Natal Depression) 07/2022
1	Social Phobia 02/2022
1	Agoraphobia 02/2022
1	Ulcer 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Fever (Fevers) 01/2022
1	Pain (Aches) 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Central Nervous System Infections (Central Nervous System Infection) 11/2021
1	Carcinogenesis 01/2021
1	Nocturnal Enuresis (Bedwetting) 01/2021

Drug/Important Bio-Agent (IBA)

21	insulin receptor-related receptor (IRR)IBA 12/2022 - 01/2013
20	Antipsychotic Agents (Antipsychotics)IBA 07/2022 - 09/2008
9	Pharmaceutical PreparationsIBA 10/2022 - 04/2006
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2009
8	Biological ProductsIBA 01/2022 - 03/2012
6	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 01/2017
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2010
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2021 - 10/2017
4	Polytetrafluoroethylene (Teflon)FDA Link 01/2022 - 06/2011
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2019
4	Silver Sulfadiazine (SSD)FDA LinkGeneric 12/2014 - 10/2008
3	Glutamic Acid (Glutamate)FDA Link 02/2020 - 01/2020
3	gamma-Aminobutyric Acid (GABA)IBA 02/2020 - 01/2020
3	Anti-Infective Agents (Microbicides)IBA 01/2019 - 01/2018
3	Antidepressive Agents (Antidepressants)IBA 01/2018 - 01/2015
3	BarbituratesIBA 12/2007 - 01/2006
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 12/2011
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022 - 11/2020
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2021
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 11/2008
2	Dronabinol (THC)FDA LinkGeneric 01/2022 - 01/2021
2	Serum AlbuminIBA 11/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 11/2021 - 01/2019
2	AlbuminsIBA 11/2021 - 01/2019
2	LipidsIBA 01/2021 - 12/2020
2	Phospholipids (Phosphatides)FDA LinkGeneric 12/2020 - 12/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 07/2016
2	AntibodiesIBA 01/2013 - 12/2011
2	Transcription Factor 4IBA 10/2011 - 08/2009
2	NeurograninIBA 10/2011 - 08/2009
2	Carbon MonoxideIBA 12/2007 - 01/2006
1	MelatoninIBA 10/2022
1	Tuberculin (PPD)IBA 07/2022
1	VaccinesIBA 05/2022
1	LithiumIBA 04/2022
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2022
1	CytokinesIBA 01/2022
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	N 30IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Medical MarijuanaIBA 01/2022
1	A-factor (Streptomyces)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 11/2021
1	Arginine Vasopressin (Argipressin)IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	4,4'-dibenzamido-2,2'-stilbenedisulfonic acidIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021

Therapy/Procedure

7	Therapeutics 02/2022 - 11/2011
4	Polypharmacy 01/2021 - 02/2010
4	Aftercare (After-Treatment) 01/2018 - 04/2005
3	Cognitive Training 01/2019 - 02/2011
2	Critical Care (Surgical Intensive Care) 09/2022 - 04/2021
2	Continuity of Patient Care 04/2021 - 01/2002
1	Vocational Rehabilitation 04/2022
1	Vagotomy 01/2022
1	Proximal Gastric Vagotomy 01/2022
1	Truncal Vagotomy 01/2022
1	Transcranial Direct Current Stimulation 11/2021
1	Transcranial Magnetic Stimulation 11/2021